News on TorreyPines Therapeutics from BioPortfolio.com http://www.BioPortfolio.com Consolidated TorreyPines Therapeutics news from BioPortfolio.com Tue, 09 Feb 2010 22:56:02 GMT en Power times twohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032789&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032789&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032789&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032789&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: Stem Cell Therapeutics Corp. Announces the Third and Final Positi...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035342&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536208733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035342&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536208733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032561&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032561&THISHREF=http://c.moreover.com/click/here.pl%3fz2534705158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032561&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032561&THISHREF=http://c.moreover.com/click/here.pl%3fz2534705158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032436&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032436&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649486%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032436&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032436&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649486%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032405&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032405&THISHREF=http://c.moreover.com/click/here.pl%3fz2534640453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032405&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032405&THISHREF=http://c.moreover.com/click/here.pl%3fz2534640453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034806&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034806&THISHREF=http://c.moreover.com/click/here.pl%3fz2535983966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034806&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034806&THISHREF=http://c.moreover.com/click/here.pl%3fz2535983966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033863&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033863&THISHREF=http://c.moreover.com/click/here.pl%3fz2535458189%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033863&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033863&THISHREF=http://c.moreover.com/click/here.pl%3fz2535458189%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTimes Live South Africa: Cell Therapeutics stock plunges on negative FDA review of cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033480&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033480&THISHREF=http://c.moreover.com/click/here.pl%3fz2535226444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033480&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033480&THISHREF=http://c.moreover.com/click/here.pl%3fz2535226444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeattle Times: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032439&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032439&THISHREF=http://c.moreover.com/click/here.pl%3fz2534652841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032439&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032439&THISHREF=http://c.moreover.com/click/here.pl%3fz2534652841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032435&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032435&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649454%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032435&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032435&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649454%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Reportlinker Adds Kinase Therapeutics: Pipeline Assessment and Commercial Prospects - Overviewhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037400&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037400&THISHREF=http://c.moreover.com/click/here.pl%3fz2537056856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037400&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037400&THISHREF=http://c.moreover.com/click/here.pl%3fz2537056856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035936&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035936&THISHREF=http://c.moreover.com/click/here.pl%3fz2536429089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035936&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035936&THISHREF=http://c.moreover.com/click/here.pl%3fz2536429089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035642&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035642&THISHREF=http://c.moreover.com/click/here.pl%3fz2536313111%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035642&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035642&THISHREF=http://c.moreover.com/click/here.pl%3fz2536313111%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Capstone Therapeutics to Present at 3rd Annual European Life Science CEO Forumhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035501&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035501&THISHREF=http://c.moreover.com/click/here.pl%3fz2536264763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035501&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035501&THISHREF=http://c.moreover.com/click/here.pl%3fz2536264763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035496&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035496&THISHREF=http://c.moreover.com/click/here.pl%3fz2536264024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035496&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=TorreyPines%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035496&THISHREF=http://c.moreover.com/click/here.pl%3fz2536264024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: